study	individual	group	count	intervention	measurement_type	substance	tissue	method	time	time_unit	value	unit	comments
Fischer2002	cyp2c9_2_S1	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	1024.85549132948	ng/ml*hr	steady state
Fischer2002	cyp2c9_2_S1	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	906.936416184971	ng/ml*hr	steady state
Fischer2002	cyp2c9_2_S2	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	693.64161849711	ng/ml*hr	steady state
Fischer2002	cyp2c9_2_S2	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	303.468208092485	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S1	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	433.526011560694	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S1	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	431.791907514451	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S2	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	395.375722543353	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S2	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	360.693641618497	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S3	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	350.28901734104	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S3	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	568.78612716763	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S4	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	343.352601156069	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S4	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	544.508670520231	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S5	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	305.202312138728	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S5	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	639.884393063584	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S6	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	300.0	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S6	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	501.156069364162	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S7	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	298.265895953757	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S7	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	478.612716763006	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S8	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	298.265895953757	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S8	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	338.150289017341	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S9	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	286.127167630058	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S9	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	294.797687861272	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S10	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	273.988439306358	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S10	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	324.277456647399	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S11	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	208.092485549133	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S11	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	232.369942196532	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S12	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	173.410404624277	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S12	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	409.248554913295	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S13	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	171.676300578035	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S13	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	296.531791907514	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S14	NA	1.0	LOS50	auc_end	losartan	plasma	HPLC/FS	24.0	hr	157.803468208092	ng/ml*hr	steady state
Fischer2002	cyp2c9_1_S14	NA	1.0	LOS50, PHE4	auc_end	losartan	plasma	HPLC/FS	24.0	hr	232.369942196532	ng/ml*hr	steady state
